MONT-SAINT-GUIBERT, Belgium, November 25, 2025–(BUSINESS WIRE)–Regulatory News:
Celyad Oncology SA (Euronext: CYAD) (“Celyad Oncology” or the “Company”) today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major shareholdings in issuers whose securities are admitted to trading on a regulated market (the “Transparency Law”), that it received a notification of transparency dated November 20, 2025, indicating that CFIP CLYD (UK) Limited, an affiliate of Fortress Investment Group LLC, has passively crossed above the 65% threshold, holding 49,050,641 voting rights, i.e. 67.77% of Celyad Oncology’s voting rights.
Content of the Notification:
-
Persons subject to the notification requirement:
Fortress Investment Group LLC – 1345 Avenue of the Americas, New York, NY 10105 United States
CFIP CLYD (UK) Limited -…
